Private equity professionals are bracing themselves for a swathe of term extensions for existing funds amid the fallout from the ongoing coronavirus crisis, new research shows.
Life sciences-focused venture capital firm Epidarex Capital has hit a £102m final close for its third fund.
MSD Partners, a subsidiary of Michael Dell's family private investment firm, has pulled in more than $1.1bn for the target-busting final close of its Real Estate Credit Opportunities Fund.
Zürich-based private equity house Evoco is almost two-thirds of the way to its €150m target for Fund III through a first close.
Wing Venture Capital has hit a $450m final close for its biggest fund to date, despite having to raise the fund virtually due to the coronavirus pandemic.
Cathay Capital has raised RMB820m ($120m) for the first close of a new fund it says will help fight climate change in tandem with a pair of green energy investors.
Mason Wells has hauled in $767m for the final close of its biggest ever fund, as it looks to boost its investments across the US Midwest.
Bankrupt and insolvent credit investment specialist Balbec Capital is gearing up for a swathe of dealmaking after beating its target for its latest fundraise through a $1.2bn final close.
Infrastructure investment specialist InstarAGF has hauled in $1.2bn for the final close of its second fund, beating its initial target.
